RA patients who are positive for serum RF and/or ACPA are defined as "seropositive" patients (SPPs) and are considered to display a different etiology, disease nature, and course compared to the so-called "seronegative" patients (SNPs) who had been described as a not well-characterized group [3]. Here, PRTN3 is linked to rheumatoid arthritis.